Google Health partners with 'telehealth' patient-doctor service

Share this article:

Google Health announced the integration of MDLiveCare technology, a service that offers patients access to doctors from remote locations, via webcam or telephone, into its personal health record offering.

The partnership, announced today during the Health 2.0 conference in San Francisco, allows MDLiveCare to flow an individual's medical data into a Google Health personal health record (PHR). A consumer can then peruse the information and records resulting from a webcam or telephone conference, and share the information with a doctor prior to an upcoming appointment, according to an MDLiveCare statement.

“Patients remember less than 25% of what they're told when they consult with a doctor,” said Bob Smoley, CEO, MDLiveCare, in the statement. “By directly synchronizing the information that's shared…we're able to provide patients with a convenient solution to review their physician or therapist encounters.”

Google Health has partnered with several other companies' online tools to sync information into Google Health PHRs, such as Quest Diagnostics, Cleveland Clinic, DestinationRx and ePillBox.info, among others.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...